Insider Transactions Reported by 26 Insiders of Aurinia Pharmaceuticals Inc.

Symbol
AUPH on Nasdaq
Location
Edmonton, Alberta, Canada

Insiders trading volume in the past year

Aurinia Pharmaceuticals Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Kevin Tang Director $173,903,490 +$26,278,806 +18% 27 Feb 2026
Peter S. Greenleaf Chief Executive Officer, Director $26,151,785 27 Feb 2026
Matthew Maxwell Donley Chief Operating Officer $9,667,048 27 Feb 2026
Joseph M. Miller Chief Financial Officer $8,190,942 27 Feb 2026
Stephen P. Robertson EVP, General Counsel $7,188,284 27 Feb 2026
Michael Robert Martin Chief Business Officer $2,918,164 02 Mar 2023
Scott Michael Habig Chief Commercial Officer $2,423,155 06 Aug 2024
Greg Keenan SVP, Chief Medical Officer $2,230,243 -$210,000 -8.6% 06 Mar 2026
Volker Knappertz EVP, Research and Development $1,946,681 27 Feb 2024
Neil Solomons Chief Medical Officer $1,024,131 02 Mar 2022
George M. Milne Jr. Director $886,534 18 May 2023
Robert Bindert Huizinga EVP of Research $781,208 02 Mar 2022
David R.w. Jayne Director $476,287 21 Nov 2024
Jeffrey A. Bailey Director $357,112 21 Nov 2025
Craig A. Johnson Director $228,802 21 Nov 2025
Jill Leversage Director $211,197 21 Nov 2024
Karen L. Smith Director $209,123 21 Nov 2024
Ph.D. Daniel Billen Director $161,529 21 May 2024
Massimilano Colao Chief Commercial Officer $151,954 02 Mar 2022
Joseph P. Hagan Director $134,681 18 May 2023
R. Hector MacKay-Dunn Former Director $106,735 09 Sep 2024
Brinda Balakrishnan Director $100,582 21 May 2024
Tina S. Nova Director 16 May 2025
Kathleen Goetz Director 16 May 2025
Timothy P. Walbert Director 18 May 2022
Dr. Robert T. Foster Director 21 Sep 2023

Recent Insider Transactions by Companies or Individuals for Aurinia Pharmaceuticals Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Greg Keenan AUPH Common Stock Tax liability -4.96% -8,069 154,449 06 Mar 2026 Direct
Kevin Tang AUPH Common Shares Purchase 1.53% $2,619,438 $14.22 184,208 12,229,500 03 Mar 2026 By LP
Kevin Tang AUPH Common Shares Purchase 1.68% $2,842,833 $14.26 199,353 12,045,292 02 Mar 2026 By LP
Joseph M. Miller AUPH Common Stock Tax liability -6.11% -37,511 576,421 02 Mar 2026 Direct
Matthew Maxwell Donley AUPH Common Stock Tax liability -5.65% -40,761 680,299 02 Mar 2026 Direct
Peter S. Greenleaf AUPH Common Stock Tax liability -5.2% -100,890 1,840,379 02 Mar 2026 Direct
Stephen P. Robertson AUPH Common Stock Tax liability -6.73% -36,525 505,861 02 Mar 2026 Direct
Kevin Tang AUPH Common Shares Purchase 4.56% $7,226,535 $13.99 516,439 11,845,939 27 Feb 2026 By LP
Joseph M. Miller AUPH Common Stock Award 10.3% 57,229 613,932 27 Feb 2026 Direct
Joseph M. Miller AUPH Employee Stock Option (right to buy) Award 95,700 95,700 27 Feb 2026 Direct
Matthew Maxwell Donley AUPH Common Stock Award 8.77% 58,160 721,060 27 Feb 2026 Direct
Matthew Maxwell Donley AUPH Employee Stock Option (right to buy) Award 97,256 97,256 27 Feb 2026 Direct
Peter S. Greenleaf AUPH Common Stock Award 11.3% 196,403 1,941,269 27 Feb 2026 Direct
Peter S. Greenleaf AUPH Employee Stock Option (right to buy) Award 328,424 328,424 27 Feb 2026 Direct
Greg Keenan AUPH Common Stock Award 33.3% 40,586 162,518 27 Feb 2026 Direct
Greg Keenan AUPH Employee Stock Option (right to buy) Award 67,870 67,870 27 Feb 2026 Direct
Stephen P. Robertson AUPH Common Stock Award 12.2% 59,090 542,386 27 Feb 2026 Direct
Stephen P. Robertson AUPH Employee Stock Option (right to buy) Award 98,813 98,813 27 Feb 2026 Direct
Matthew Maxwell Donley AUPH Common Stock Tax liability -4.73% -32,901 662,900 20 Feb 2026 Direct
Peter S. Greenleaf AUPH Common Stock Tax liability -5.43% -100,171 1,744,866 20 Feb 2026 Direct
Joseph M. Miller AUPH Common Stock Tax liability -5.5% -32,424 556,703 20 Feb 2026 Direct
Stephen P. Robertson AUPH Common Stock Tax liability -6.69% -34,638 483,296 20 Feb 2026 Direct
Greg Keenan AUPH Common Stock Tax liability -8.65% -11,552 121,932 02 Feb 2026 Direct
Stephen P. Robertson AUPH Common Stock Tax liability -7.23% -40,385 517,934 02 Jan 2026 Direct
Stephen P. Robertson AUPH Common Stock Award 9.54% 48,558 557,434 02 Jan 2026 Direct
Matthew Maxwell Donley AUPH Common Stock Tax liability -5.79% -42,787 695,801 02 Jan 2026 Direct
Matthew Maxwell Donley AUPH Common Stock Award 7.96% 54,166 734,631 02 Jan 2026 Direct
Joseph M. Miller AUPH Common Stock Tax liability -6.38% -40,161 589,127 02 Jan 2026 Direct
Joseph M. Miller AUPH Common Stock Award 8.49% 49,038 626,399 02 Jan 2026 Direct
Peter S. Greenleaf AUPH Common Stock Tax liability -5.78% -113,169 1,845,037 02 Jan 2026 Direct
Peter S. Greenleaf AUPH Common Stock Award 9.24% 165,384 1,954,329 02 Jan 2026 Direct
Jeffrey A. Bailey AUPH Common Shares Tax liability -10.6% -2,716 22,775 21 Nov 2025 Direct
Craig A. Johnson AUPH Common Shares Tax liability -29.3% -6,039 14,592 21 Nov 2025 Direct
Kevin Tang AUPH Common Shares Purchase 1.8% $2,336,000 $11.68 200,000 11,329,500 05 Aug 2025 By LP
Kevin Tang AUPH Common Shares Purchase 0.91% $1,134,000 $11.34 100,000 11,129,500 04 Aug 2025 By LP
Kevin Tang AUPH Common Shares Purchase 9.97% $10,120,000 $10.12 1,000,000 11,029,500 01 Aug 2025 By LP
Greg Keenan AUPH Common Stock Sale -13% $210,000 $10.50 -20,000 133,484 01 Aug 2025 Direct
Tina Susan Nova AUPH Director Stock Option (right to buy) Award 63,724 63,724 16 May 2025 Direct
Craig A. Johnson AUPH Director Stock Option (right to buy) Award 37,485 37,485 16 May 2025 Direct
Kathleen Goetz AUPH Director Stock Option (right to buy) Award 63,724 63,724 16 May 2025 Direct
Jeffrey A. Bailey AUPH Director Stock Option (right to buy) Award 37,485 37,485 16 May 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.